Your browser doesn't support javascript.
loading
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
Schmassmann, Philip; Roux, Julien; Buck, Alicia; Tatari, Nazanin; Hogan, Sabrina; Wang, Jinyu; Rodrigues Mantuano, Natalia; Wieboldt, Ronja; Lee, Sohyon; Snijder, Berend; Kaymak, Deniz; Martins, Tomás A; Ritz, Marie-Françoise; Shekarian, Tala; McDaid, Marta; Weller, Michael; Weiss, Tobias; Läubli, Heinz; Hutter, Gregor.
Afiliación
  • Schmassmann P; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Roux J; Bioinformatics Core Facility, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Buck A; Swiss Institute of Bioinformatics, 4031 Basel, Switzerland.
  • Tatari N; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland.
  • Hogan S; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Wang J; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Rodrigues Mantuano N; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Wieboldt R; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Lee S; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Snijder B; Institute of Molecular Systems Biology, ETH Zurich, 8049 Zurich, Switzerland.
  • Kaymak D; Institute of Molecular Systems Biology, ETH Zurich, 8049 Zurich, Switzerland.
  • Martins TA; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Ritz MF; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Shekarian T; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • McDaid M; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Weller M; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
  • Weiss T; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland.
  • Läubli H; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland.
  • Hutter G; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.
Sci Transl Med ; 15(705): eadf5302, 2023 07 19.
Article en En | MEDLINE | ID: mdl-37467314
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ácido N-Acetilneuramínico Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ácido N-Acetilneuramínico Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos